Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

TAK-085

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The effects of cholesterol-lowering statins, which substantially benefit future cardiovascular events, on fatty acid metabolism… Expand
Highly Cited
2015
Highly Cited
2015
We investigated whether a highly purified eicosapentaenoic acid (EPA) and a concentrated n-3 fatty acid formulation (prescription… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
2015
2015
Summary Background Low‐density lipoproteins (LDLs) comprise a heterogeneous group of particles with various size and density. A… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
2014
2014
The omega-3 polyunsaturated fatty acids (ω-3 PUFAs) docosahexaenoic acid (DHA) and/or eicosapentaenoic acid (EPA) protect against… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
2013
2013
BACKGROUND Hypertriglyceridemia is a risk factor for cardiovascular disease, and clinical practice guidelines advocate treatment… Expand
2013
2013
BACKGROUND TAK-085 is an omega-3 preparation that contains eicosapentaenoic acid ethyl-ester (EPA-E) and docosahexaenoic acid… Expand
2013
2013
Metabolic syndrome is implicated in the decline of cognitive ability. We investigated whether the prescription n-3 fatty acid… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
2011
2011
Deposition of amyloid β peptide (Aβ) into the brain causes cognitive impairment. We investigated whether prescription pre… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2